A multicenter, open-label trial to assess the long-term safety and efficacy of lacosamide in subjects with painful diabetic neuropathy.
Phase of Trial: Phase III
Latest Information Update: 25 Nov 2016
At a glance
- Drugs Lacosamide (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Adverse reactions; Registrational
- Sponsors Schwarz BioSciences; Schwarz Pharma AG; UCB
- 15 Sep 2009 UCB added as trial sponsor and affiliate as reported by ClinicalTrials.gov.
- 03 Jan 2008 Status changed from in progress to completed.
- 30 Dec 2005 New trial record.